Magnesium is required for the function of GABA-A receptors — the primary inhibitory receptors in the central nervous system. Without adequate magnesium, NMDA glutamate receptors become overactive, producing a state of neurological excitability that presents as anxiety, irritability, hypervigilance, and difficulty with sleep onset. Magnesium acts as a natural NMDA receptor antagonist, physically blocking the channel when voltage thresholds are not met. It also modulates the HPA axis, reducing cortisol output during stress. Deficiency is prevalent — estimated at over 50% of the U.S. population — and is consistently associated with elevated anxiety scores.

The glycinate chelate binds magnesium to glycine, which itself has inhibitory neurotransmitter activity — providing a secondary calming mechanism. This form has the highest bioavailability of any magnesium compound and produces minimal gastrointestinal side effects. 400mg is the therapeutic dose consistently used in human studies demonstrating reductions in anxiety and improvements in sleep quality. Given widespread dietary insufficiency, 400mg in a bioavailable chelated form meaningfully corrects functional deficiency in most individuals.

NAC is the rate-limiting precursor to glutathione, the brain's primary antioxidant. Chronic psychological stress depletes glutathione, creating an oxidative environment that impairs neuronal function and sustains the hyperactivated stress response. Beyond antioxidant action, NAC directly modulates glutamate-cystine transport via the xCT antiporter, reducing synaptic glutamate availability — the neurotransmitter most responsible for neural excitability and anxiety amplification. It reduces neuroinflammation, supports mitochondrial function in neurons, and attenuates the excitatory excess that underlies rumination and catastrophic thinking.

Clinical trials in anxiety and OCD-spectrum conditions have used 600–2,400mg/day. 600mg is the foundational dose — effective for glutathione replenishment and modest glutamate modulation, with the best tolerability profile. Higher doses are used for more severe presentations and are not necessary for the daily stress and anxiety support this formula addresses. NAC at 600mg is well-tolerated with no clinically meaningful drug interactions at standard anxiolytic doses.

Apigenin is a flavonoid — the primary bioactive compound in chamomile — with a well-characterized mechanism of action: it binds to the benzodiazepine site on GABA-A receptors, acting as a partial positive allosteric modulator. This means it enhances the inhibitory signaling of GABA without the full receptor occupancy that causes sedation, tolerance, or dependency seen with pharmaceutical benzodiazepines. The result is a measurable reduction in anxiety and physiological arousal without cognitive suppression. Apigenin also carries anti-inflammatory activity in neural tissue.

The 50mg dose of isolated apigenin corresponds to the concentration found in standardized chamomile extracts used in clinical anxiety trials. Unlike chamomile tea — where apigenin content is variable and low — 50mg delivers a consistent and clinically meaningful dose. It is sufficient to produce GABAergic activity without sedation during waking hours. It is not habit-forming and does not appear to produce receptor downregulation with continuous use.

L-theanine is a non-proteinogenic amino acid found almost exclusively in tea leaves. It crosses the blood-brain barrier and increases alpha brain wave activity — the oscillatory state associated with relaxed, present-moment awareness. It directly increases GABA and dopamine levels while inhibiting excitatory glutamate activity, producing a distinct cognitive state: calm without sedation, focused without stimulation. It attenuates physiological stress markers including heart rate variability, salivary cortisol, and sympathetic nervous system activation during acute stress tasks.

200mg is the well-validated threshold for measurable anxiolytic and cognitive effects. This formula uses 350mg to deliver a more pronounced calming response appropriate for individuals with moderate-to-significant anxiety burden, while remaining below the threshold where sedation becomes a factor. At 350mg, L-theanine synergizes meaningfully with both apigenin (additive GABAergic support) and magnesium (complementary glutamate modulation) to produce a compound effect that exceeds any single ingredient alone.